Pharmaceutical Technology
NOVEMBER 15, 2022
Cost is an important final factor, especially for small and mid-sized pharma companies. To boost the profitability of the drug at a later stage in its lifecycle, manufacturers may then consider changing the presentation to prefilled syringes. When launching a new vaccine, vials tend to be chosen.
Delveinsight
NOVEMBER 29, 2020
Looking at the potential of the pipeline therapies they hold once approved, pharmaceutical companies are charting out a seemingly exciting course in the market. Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market.
Pharmaceutical Technology
MARCH 22, 2023
The injectable drugs market is currently valued at around $532 billion. Yet while demand for injectables soars, regulators are cracking down on quality requirements, forcing many pharma companies to examine the role – and risks – of their primary packaging.
Expert insights. Personalized for you.
130 
Let's personalize your content